Literature DB >> 16773561

Mapping tumor-suppressor genes with multipoint statistics from copy-number-variation data.

Iuliana Ionita1, Raoul-Sam Daruwala, Bud Mishra.   

Abstract

Array-based comparative genomic hybridization (arrayCGH) is a microarray-based comparative genomic hybridization technique that has been used to compare tumor genomes with normal genomes, thus providing rapid genomic assays of tumor genomes in terms of copy-number variations of those chromosomal segments that have been gained or lost. When properly interpreted, these assays are likely to shed important light on genes and mechanisms involved in the initiation and progression of cancer. Specifically, chromosomal segments, deleted in one or both copies of the diploid genomes of a group of patients with cancer, point to locations of tumor-suppressor genes (TSGs) implicated in the cancer. In this study, we focused on automatic methods for reliable detection of such genes and their locations, and we devised an efficient statistical algorithm to map TSGs, using a novel multipoint statistical score function. The proposed algorithm estimates the location of TSGs by analyzing segmental deletions (hemi- or homozygous) in the genomes of patients with cancer and the spatial relation of the deleted segments to any specific genomic interval. The algorithm assigns, to an interval of consecutive probes, a multipoint score that parsimoniously captures the underlying biology. It also computes a P value for every putative TSG by using concepts from the theory of scan statistics. Furthermore, it can identify smaller sets of predictive probes that can be used as biomarkers for diagnosis and therapeutics. We validated our method using different simulated artificial data sets and one real data set, and we report encouraging results. We discuss how, with suitable modifications to the underlying statistical model, this algorithm can be applied generally to a wider class of problems (e.g., detection of oncogenes).

Entities:  

Mesh:

Year:  2006        PMID: 16773561      PMCID: PMC1474131          DOI: 10.1086/504354

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  15 in total

1.  Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase.

Authors:  Y Wu; D Dowbenko; S Spencer; R Laura; J Lee; Q Gu; L A Lasky
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

2.  An approximation for the distribution of the scan statistic.

Authors:  S Wallenstein; N Neff
Journal:  Stat Med       Date:  1987-03       Impact factor: 2.373

3.  Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer.

Authors:  Ruo-Chia Tseng; Jer-Wei Chang; Feng-Jen Hsien; Ya-Hui Chang; Chin-Fu Hsiao; Jung-Ta Chen; Chih-Yi Chen; Yuh-Shan Jou; Yi-Ching Wang
Journal:  Int J Cancer       Date:  2005-11-01       Impact factor: 7.396

4.  Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis.

Authors:  P Karnik; M Paris; B R Williams; G Casey; J Crowe; P Chen
Journal:  Hum Mol Genet       Date:  1998-05       Impact factor: 6.150

5.  Loss of heterozygosity on the long arm of chromosome 21 in non-small cell lung cancer.

Authors:  Eung Bae Lee; Tae In Park; Sun Ha Park; Jae Yong Park
Journal:  Ann Thorac Surg       Date:  2003-05       Impact factor: 4.330

6.  Transfer of human chromosome 3 to an ovarian carcinoma cell line identifies three regions on 3p involved in ovarian cancer.

Authors:  P Rimessi; F Gualandi; C Morelli; C Trabanelli; Q Wu; L Possati; M Montesi; J C Barrett; G Barbanti-Brodano
Journal:  Oncogene       Date:  1994-12       Impact factor: 9.867

7.  Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.

Authors:  Montserrat Sanchez-Cespedes; Paola Parrella; Manel Esteller; Shuji Nomoto; Barry Trink; James M Engles; William H Westra; James G Herman; David Sidransky
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  Molecular characterization of the human PLC beta1 gene.

Authors:  Daniela Peruzzi; Michela Aluigi; Lucia Manzoli; Anna Maria Billi; Francesco Paolo Di Giorgio; Manuela Morleo; Alberto M Martelli; Lucio Cocco
Journal:  Biochim Biophys Acta       Date:  2002-09-05

10.  A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung.

Authors:  S Hosoe; K Ueno; Y Shigedo; I Tachibana; T Osaki; T Kumagai; Y Tanio; I Kawase; Y Nakamura; T Kishimoto
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

View more
  4 in total

1.  Target inference from collections of genomic intervals.

Authors:  Alexander Krasnitz; Guoli Sun; Peter Andrews; Michael Wigler
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-06       Impact factor: 11.205

2.  Copy number variant analysis of human embryonic stem cells.

Authors:  Hao Wu; Kevin J Kim; Kshama Mehta; Salvatore Paxia; Andrew Sundstrom; Thomas Anantharaman; Ali I Kuraishy; Tri Doan; Jayati Ghosh; April D Pyle; Amander Clark; William Lowry; Guoping Fan; Tim Baxter; Bud Mishra; Yi Sun; Michael A Teitell
Journal:  Stem Cells       Date:  2008-03-27       Impact factor: 6.277

3.  Breaking the waves: improved detection of copy number variation from microarray-based comparative genomic hybridization.

Authors:  John C Marioni; Natalie P Thorne; Armand Valsesia; Tomas Fitzgerald; Richard Redon; Heike Fiegler; T Daniel Andrews; Barbara E Stranger; Andrew G Lynch; Emmanouil T Dermitzakis; Nigel P Carter; Simon Tavaré; Matthew E Hurles
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

4.  Inferring tree causal models of cancer progression with probability raising.

Authors:  Loes Olde Loohuis; Loes Olde Loohuis; Giulio Caravagna; Alex Graudenzi; Daniele Ramazzotti; Giancarlo Mauri; Marco Antoniotti; Bud Mishra
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.